Plasmodium falciparum 19 kDa of merozoite surface protein-1 (MSP-119) expressed in Mycobacterium bovis bacille Calmette Guerin (BCG) is reactive with an inhibitory but not a blocking monoclonal antibody

Tropical Biomedicine

Volumn 27, Issue 1, 2010, Pages 60-67

  Nurul, A A ^a   Rapeah, S ^a   Norazmi, M N ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

MEROZOITE SURFACE PROTEIN 1; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MUTATION; MYCOBACTERIUM BOVIS; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM BOVIS; PLASMODIUM FALCIPARUM;

EID: 77949638012     PISSN: 01275720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Blackman, M.J., Heidrich, H.G., Donachie, S., McBride, J.S. & Holder, A.A. (1990). A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. Journal of Experimental Medicine 172: 379-382.
2. Charlet, D., Mostowy, S., Alexander, D., Sit, L., Wiker, H.G. & Behr, M.A. (2005). Reduced expression of antigenic proteins MPB70 and MPB83 in M. bovis BCG strains due to a start codon mutation in sigK. Molecular Microbiology 56: 1302-1313.
3. da Cruz, F.W., McBride, A.J.A., Conceição, F.R., Dale, J.W., McFadden, J. & Dellagostin, O.A. (2001). Expression of the B-cell and T-cell epitopes of the rabies virus nucleoprotein in M. bovis BCG and induction of an humoral response in mice. Vaccine 20: 731-736.
4. Dale, J.W. & Patki, A. (1990). Mycobacterial gene expression and regulation. In: McFadden J, ed. Molecular Biology of Mycobacteria. Surrey: Surrey University Press, pp. 173-198.
5. Dennehy, M. & Williamson, A.L. (2005). Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine 23: 1209-1224.
6. Franco-Paredes, C., Rouphael, N., del Rio, C. & Santos-Preciado, J.I. (2006). Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates. International Journal of Infectious Diseases 10: 93-102.
7. Gardner, M.J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R.W., Carlton, J.M., Pain, A., Nelson, K.E., Bowman, S., Paulsen, I.T., James, K., Eisen, J.A., Rutherford, K., Salzberg, S.L., Craig, A., Kyes, S., Chan, M.S., Nene, V., Shallom, S.J., Suh, B., Peterson, J., Angiuoli, S., Pertea, M., Allen, J., Selengut, J., Haft, D., Mather, M.W., Vaidya, A.B., Martin, D.M., Fairlamb, A.H., Fraunholz, M.J., Roos, D.S., Ralph, S.A., McFadden, G.I., Cummings, L.M., Subramanian, G.M., Mungall, C., Venter, J.C., Carucci, D.J., Hoffman, S.L., Newbold, C., Davis, R.W., Fraser, C.M. & Barrell, B. (2002). Genome sequence of the human malaria parasite P. falciparum. Nature 419: 498-511.
8. Greenwood, B. (2005). Malaria vaccines: Evaluation and implementation. Acta Tropica 95: 298-304.
9. Himmelrich, H., Lo-Man, R., Winter, N., Guermonprez, P., Sedlik, C., Rojas, M., Monnaie, D., Gheorghiu, M., Lagranderie, M., Hofnung, M., Gicquel, B., Clement, J.M. & Leclerc, C. (2000). Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: malE. Vaccine 18: 2636-2647.
10. Ling, I.T., Ogun, S.A. & Holder, A.A. (1994). Immunization against malaria with a recombinant protein. Parasite Immunology 16: 63-67.
11. Matsumoto, S., Yukitake, H., Kanbara, H. & Yamada, T. (1998). Recombinant M. bovis BCG secreting merozoite surface protein 1(MSP-1) induces protection against rodent malaria parasite infection depending on MSP-1 stimulated interferon-g and parasite-specific antibodies. Journal of Experimental Medicine 188: 845-854.
12. Miller, B.H. & Shinnick, T.M. (2000). Evaluation of M. tuberculosis genes involved in resistance to killing by human macrophages. Infection and Immunity 68: 387-390.
13. Morgan, W.D., Birdsall, B., Frenkiel, T.A., Gradwell, M.G., Burghaus, P.A. & Syed, S.E.H. (1999). Solution structure af an EGF module pair from the P. falciparum merozoite surface protein 1. Journal of Molecular Biology 209: 113-122.
14. Nascimento, I.P., Waldely, O.D., Rogerio, P.M., Eliane, N.M., Gamberini, M., Quintilio, W., Gebara, V.C., Cardoso, D.F., Ho, P.L., Raw, I., Winter, N., Gicquel, B., Rappuoli, R. & Leite, L.C.C. (2000). Recombinant M. bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infection and Immunity 68: 4877-4883.
15. Nascimento, I.P., Dias, W.O., Quintilio, W., Hsud, T., Jacobs Jr., W.R. & Leite, L.C.C. (2009). Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: Protection against Bordetella pertussis challenge in neonates. Vaccine 27: 7346-7351.
16. Norazmi, M.N., Zainuddin, Z.F., Suppian, R. & Dale, J.W. (1999). The use of assembly PCR for cloning of a malarial epitope into M. smegmatis - importance of overcoming codon bias. Biotechnology Techniques 13: 485-489.
17. Patino, J.A.G., Holder, A.A., McBride, J.S. & Blackman, M.J. (1997). Antibodies that inhibit malaria MSP-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. Journal of Experimental Medicine 186: 1689-1699.
18. Sachdeva, S., Ahmad, G., Malhotra, P., Mukherjee, P. & Chauhan, V.S. (2004). Comparison of immunogenicities of recombinant P. vivax merozoite surface protein 1 19- and 42-kDa fragments expressed in Escherichia coli. Infection and Immunity 72: 5775-5782.
19. Stemmer, W.P.C., Crameri, A., Brennan, T.M. & Heynecker, H.L. (1995). Single step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Nature 351: 456-460.
20. Sterne, J.A.C., Rodrigues, L.C. & Guedes, I.N. (1998). Does the efficacy of BCG decline with time since vaccination? International Journal of Tuberculosis and Lung Disease 2: 200-207.
21. Stover, C.K., Bansal, G.P., Hanson, M.S., Burlein, J.E., Palaszynski, S.R. & Young, J.F. (1993). Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. Journal of Experimental Medicine 178: 197-209.
22. Uthaipibull, C., Syed, S.E.H., Patino, J.A.G., Ling, I.T. & Holder, A.A. (2001). Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 2 of the malaria parasite P. falciparum. Journal of Molecular Biology 307: 1381-1394.
23. WHO. (2008). World Malaria Report. WHO Geneva, Switzerland.
24. Wang, H., Liu, Q., Liu, K., Zhong, W., Gao, S., Jiang, L. & An, N. (2007). Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. Parasitology International 56: 263-268.
25. Wiker, H.G., Nagai, S., Hewinson, R.G., Russell, W.P. & Harboe, M. (1996). Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of M. bovis BCG and M. tuberculosis H37Rv. Scandinavian Journal of Immunology 43: 374-380.
26. Zheng, C.F., Xie, P.M. & Chen, Y.T. (2003). Immune response induced by rBCG expressing merozoite surface antigen 2 from P. falciparum. Vaccine 20: 914-919.